《歐洲藥理學(xué)雜志》發(fā)表關(guān)于影響生物系統(tǒng)的化學(xué)物質(zhì)作用機制的長篇論文、簡短通訊和快速通訊。該雜志還審議了旨在討論其范圍內(nèi)迅速發(fā)展領(lǐng)域的最新進展的簡短評論(印刷不超過12頁)。完整的論文和簡短的交流按以下標(biāo)題分類:行為藥理學(xué)、神經(jīng)藥理學(xué)和鎮(zhèn)痛、心血管藥理學(xué)、肺、胃腸和泌尿生殖藥理學(xué)、內(nèi)分泌藥理學(xué)、免疫藥理學(xué)和炎癥、分子和細(xì)胞藥理學(xué)。手稿提交給《華爾街日報》被接受理解:(1)主題編輯審查,(2)他們沒有,不會發(fā)表在全部或部分在其他雜志,和(3)建議從赫爾辛基宣言和國際公認(rèn)原則的使用實驗動物一直堅持。

The European Journal of Pharmacology publishes full-length papers, short communications and rapid communications on the mechanisms of action of chemical substances affecting biological systems. The journal also considers short reviews (not exceeding 12 pages in print) intended to debate recent advances in rapidly developing fields that are within its scope.Full-length papers and short communications are grouped under the following headings: Behavioral pharmacology, Neuropharmacology and analgesia, Cardiovascular pharmacology, Pulmonary, gastrointestinal and urogenital pharmacology, Endocrine pharmacology, Immunopharmacology and inflammation, and Molecular and cellular pharmacology. Manuscripts submitted to the journal are accepted on the understanding that: (1) they are subject to editorial review, (2) they have not been and will not be published in whole or in part in any other journal, and (3) the recommendations from the declaration of Helsinki and the internationally accepted principles in the use of experimental animals have been adhered to.